Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1Frédérique-Anne Le Gal, Maha Ayyoub, Valérie Dutoit, et al.
Science Immunology|November 1, 2022
Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccinationYacine Maringer, Annika Nelde, Sarah M Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinomaArjen Sloots, Cristina Mastini, Florian Rohrbach, et al.
Journal for Immunotherapy of Cancer|January 10, 2023
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancerJulia Karbach, Dragan Kiselicki, Kathrin Brand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DRYuansheng Sun, Mingxia Song, Elke Jäger, et al.
Genes & Development|February 17, 2006
Acetylation of Stat1 modulates NF-kappaB activityOliver H Krämer, Daniela Baus, Shirley K Knauer, et al.
International Journal of Cancer|September 10, 2005
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011Julia Karbach, Claudia Pauligk, Armin Bender, et al.
Oncoimmunology|October 7, 2025
Tumor-infiltrating lymphocytes-derived CD8+ clonotypes infiltrate the tumor tissue and mediate tumor regression in glioblastomaLucas C M Arruda, Julia Karbach, Dragan Kiselicki, et al.
Pageof 12